Synthesize Bio
Seattle, Washington, United States · Biotechnology · 16 employees
Synthesize Bio is a biotechnology company pioneering biological foundation models to simulate the results of gene expression experiments. They develop generative genomics models that enable researchers to predict experimental outcomes and enhance drug development processes. Founded by experts in RNA informatics and translational data science, the company focuses on helping biopharmaceutical compan
Funding history
- Series seed — $10.0M — Sep 2025
Recent signals
- Sep 17, 2025: Raised $10.0M in Series seed
See plans & pricing → Track Synthesize Bio’s funding, hiring, and signals — with verified contacts — on Fundz.